Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2011
02/02/2011CN101961331A Ubiquitin E1 inhibitor and preparation method thereof
02/02/2011CN101961330A Anti-stress agent for aquatic livestock
02/02/2011CN101961329A Application of Silibinin in preparing anti-male hormone medicaments
02/02/2011CN101961328A Application of sodium houttuyfonate as synergist of antifungal medicament
02/02/2011CN101961327A Application of toremifene for preparing medicine of treating androgen-deprivation induced mammogenesis in a male subject
02/02/2011CN101961326A Application of physcion in preparing medicines for treating depression
02/02/2011CN101961325A Application of emodin in preparation of drugs for treating depression
02/02/2011CN101961324A Prescription and preparation method of etofbrate release capsules
02/02/2011CN101961323A Self-emulsified resveratrol soft capsules
02/02/2011CN101961322A Medicinal composition for treating hyperlipidaemia
02/02/2011CN101961321A Zinc gluconate sugar tablet preparation and preparation method thereof
02/02/2011CN101961320A Budesonide nano crystallizing preparation and preparation method thereof
02/02/2011CN101961319A Silybin meglumine enteric agent with high bioavailability and preparation method thereof
02/02/2011CN101961318A Lappaconitine sustained release microspheres for injection and preparation method thereof
02/02/2011CN101961316A LID-PEG-PLGA controlled-release nano microsphere and preparation method thereof
02/02/2011CN101961315A Ornithine aspartate liposome injection
02/02/2011CN101961313A Itraconazole nanocrystals and preparation method and application thereof
02/02/2011CN101961312A Lipoid acid composition for injection
02/02/2011CN101961311A 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method thereof
02/02/2011CN101961310A Preparation technology of ligustrazine hydrochloride injecting liquid
02/02/2011CN101961309A Process for preparing pantoprazole sodium for injection
02/02/2011CN101961308A Methylprednisolone aceponate cream preparation
02/02/2011CN101961307A Oral liquid for treating respiratory disease and preparation method thereof
02/02/2011CN101961156A Nano AgFe2O3 antibacterial deodorization far infrared magnetic health-care shoe
02/02/2011CN101961034A Medicament for treating fish gill-rot diseases
02/02/2011CN101721379B Cefuroxime sodium suspension powder injection
02/02/2011CN101716153B Ornidazole ester microsphere solid preparation
02/02/2011CN101653413B Tacrolimus ophthalmic emulsion and its preparation method
02/02/2011CN101642431B Ozagrel sodium liposome injection
02/02/2011CN101623285B Cefmetazole sodium medicament and preparation method thereof
02/02/2011CN101623262B Cephazolin sodium pentahydrate proliposome preparation
02/02/2011CN101623258B Ranitidine hydrochloride lipidosome capsule and new application thereof
02/02/2011CN101612138B Cefetamet pivoxil hydrochloride capsule and preparation method thereof
02/02/2011CN101612120B Fleroxacin freeze-dry emulsion and production method thereof
02/02/2011CN101596208B Medicine composition for treating burns, scalds, tympanitis and ulceratiue stomatitis
02/02/2011CN101596177B Coenzyme Q10 self-emulsifying composition, preparation method and application thereof
02/02/2011CN101590035B Application of dehydrogenated silybin in preparing anti-lung-cancer medicament
02/02/2011CN101569654B Application of pigeon pea stilbene acid in the preparation of antitumor drug
02/02/2011CN101559108B Chinese medicinal preparation for treating beriberi, tinea corporis, tinea cruris and method for preparing same
02/02/2011CN101544952B Oxytropis ehrig cinerea FEL4-OOc and separation method and application thereof
02/02/2011CN101536999B Application of 3,5-dimethoxy-4-hydroxy benzaldehyde in ray protection
02/02/2011CN101513399B Application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder
02/02/2011CN101502580B External-use medicament for treating tinea manus and pedis
02/02/2011CN101491535B Method for preparing azithromycin composition with reduced bitter
02/02/2011CN101491500B Meglumine adenosine cyclphosphate microspheres and production method thereof
02/02/2011CN101485679B Medicament for preventing and treating hyperlipemia
02/02/2011CN101475576B Flavone lignose compound, and preparation and pharmaceutical use thereof
02/02/2011CN101468029B Difructose anhydride-containing composition and use thereof
02/02/2011CN101468023B Exemestane tablet and technique for preparing the same
02/02/2011CN101456890B Specificity inhibitor of leukaemia bcr/abl fusion gene mRNA
02/02/2011CN101450038B Nicarbazin and ethopabate nano suspension agent and preparation method thereof
02/02/2011CN101444503B Efficient long-acting silibinin preparation and preparation method thereof
02/02/2011CN101440073B Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof
02/02/2011CN101434570B Pyrrolidine derivative, and preparation and use thereof
02/02/2011CN101429175B Perilla alcohol derivant with antineoplastic activity and uses thereof
02/02/2011CN101407558B Preparation of Dendrobium nobile polysaccharide extract and use there
02/02/2011CN101401833B Composition for preventing and/or treating osteoporosis
02/02/2011CN101396507B Traditional Chinese medicine antibacterial liquid and preparation method and use thereof
02/02/2011CN101396360B Medicine lotion for treating skin or scalp superficial part mycotic infection and preparation method thereof
02/02/2011CN101362765B 5,7-diaminopyrazolo '4,3-d-pyrimidines with PDE-5 inhibiting activity
02/02/2011CN101343290B Preparation method for adefovir dipivoxil ester waterless crystallization article, prepared adefovir dipivoxil ester waterless crystallization article and uses thereof
02/02/2011CN101337015B Traditional Chinese medicine for gynecology and dermatology and preparation method thereof
02/02/2011CN101307041B Novel taxane halogenation derivates with anti-tumor activity
02/02/2011CN101291671B Liquid preparation for external application containing indomethacin
02/02/2011CN101289418B Miglitol crystal and method for preparing same
02/02/2011CN101273970B Microemulsion type preparation of glucocorticoid medicine for nasal cavity
02/02/2011CN101270060B 2,6-(amino-benzene methylene)naphthenone compounds, preparation method and application thereof
02/02/2011CN101217966B Combination therapy of cancer with AZD2171 and gemcitabine
02/02/2011CN101213193B Mono-lysine salts of azole compounds
02/02/2011CN101212987B Self-sterilizing products
02/02/2011CN101203246B Medical composition
02/02/2011CN101195570B Salt amino acid of ferulic acid
02/02/2011CN101156933B A medicine for treating cerebrovascular disease
02/02/2011CN101147732B Application of chlorogenic acid in preparing medicine for preventing and treating nasopharyngeal cancer
02/02/2011CN101143846B Metal salt of quinaprilat
02/02/2011CN101143166B Medicine for swelling and relieving pain and its preparation method and application
02/02/2011CN101137657B Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
02/02/2011CN101129354B Pharmaceutical composition containing triacetyl andrographolidume and medical use of the same
02/02/2011CN101119726B Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
02/02/2011CN101088510B Use of Cordycepic polysaccharide in pharmacy
02/02/2011CN101073552B Double hydrochloride vertebral gel spray for purifying nose and its use
02/02/2011CN101068544B Radionuclide-chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method
02/02/2011CN101015682B Medicine composition with compact bone substance density improving function, preparing process and quality controlling means thereof
02/01/2011USRE42096 FDA Orange book listed patent for amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate; sustained release for improved patient compliance, fewer dosages needed; attention deficit
02/01/2011US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
02/01/2011US7880013 such as N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide, havu=ing adenosine receptor antagonistic activity, used for treating Parkinson's disease, Alzheimer's disease, creutfildt-jacob disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's chorea, atrophy and ischemia
02/01/2011US7880010 Crystalline forms of a dimethylphenyl compound
02/01/2011US7880009 Cinnamide compound
02/01/2011US7880008 Heterocycles useful as modulators of ion channels
02/01/2011US7880007 Bicyclic substituted phenyl piperidine modulators of muscarinic receptors
02/01/2011US7880006 Quinoline derivatives and insecticide comprising thereof as active ingredient
02/01/2011US7880004 protein tyrosine kinase inhibitors such as 4-(1H-Pyrrolo[2,3-b]pyridin-4-yloxy)-2,5-difluoro-N-(1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridin-3-yl)benzamide, trifluoroacetic acid salt, useful for the treatment of cancer
02/01/2011US7880002 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
02/01/2011US7880001 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
02/01/2011US7880000 N-(5-(1,1- dimethylethyl)-3- isoxazolyl)-4-methyl-3- ((3-(4-pyrimidinyl)-2- pyridinyl)amino)benzamide, used for treating breast cancer or rheumatoid arthritis
02/01/2011US7879997 Tumor necrosis factor-alpha converting enzyme inhibitors such as (2S,3R)-4-oxo-3-[[4-[(2-phenylquinolin-4-yl)methoxy]phenyl]methyl]azetidine-2-carboxylic acid, useful for the treatment of diseases or conditions mediated by matrix Metalloproteinases and tumor necrosis factor-alpha
02/01/2011US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes
02/01/2011US7879983 Binding member which binds to both Lewis-y and Lewis-b haptens, and its use for treating cancer
02/01/2011US7879966 pH-sensitive polymer
02/01/2011US7879914 Methods for treating viral infections using polyamine analogs